期刊文献+

淫羊藿甙对大鼠成骨细胞护骨素、RANKL表达的影响 被引量:65

Effects of icariin on the expressions of osteoprotegerin and RANKL in rat osteoblasts
原文传递
导出
摘要 目的观察淫羊藿甙对体外培养大鼠成骨细胞护骨素(OPG)、核因子-kB受体活化因子配体(RANKL)mRNA表达的影响。方法用酶消化法分离24h内新生SD大鼠颅盖骨成骨细胞,进行原代培养。在培养液中加入不同浓度的淫羊藿甙(10^(10)~10^(14)mol/L),培养48h后,抽提总RNA,采用半定量RT-PCR法检测成骨细胞中OPG和RANKL mRNA表达的变化。结果淫羊藿甙可明显促进成骨细胞OPG mRNA的表达,抑制RANKL mRNA的表达,且呈浓度依赖性,均以10^(-7)mol/L时作用最显著(P<0.05)。预先用淫羊藿甙干预成骨细胞,可逆转地塞米松的降低OPG mRNA(0.570±0.093vs 1.083±0.081)、升高RANKL mRNA(1.079±0.050vs 0.718±0.082)的作用(均P<0.05)。结论淫羊藿甙可以上调OPG基因表达,下调RANKL基因表达,从而调节骨吸收,这可能是淫羊藿甙防治骨质疏松症的重要机制之一。 Objective To investigate the effects of icariin on the expressions of osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) mRNA in rat osteoblasts cultured in vitro. Methods Calvarial osteoblasts were obtained from newborn SD rats aged 〈 24 h by trypsin-collagenase digestion method. After treatment with different concentrations of icariin (10^-10-10^-4 mol/L) for 48 h, total RNA was isolated from osteoblasts. Expressions of OPG and RANKL mRNA were detected by semiquantitative RT-PCR. Results Icariin remarkably increased OPG mRNA levels and decreased RANKL mRNA levels in calvarial osteoblasts in a dosedependent fasion with a maximum effect at a concentration of 10^-7 mol/L (P 〈0.05 ). Osteoblasts pre-treated with icariin prevented the inhibitory effect of dexamethasone on OPG mRNA (0. 570 ± 0. 093 vs 1. 083 ± 0.081 ) and the stimulative effect on RANKL mRNA(1.079 ±0.050 vs 0.718 ±0.082) (both P〈0.05). Conclusion Icariin upregulates OPG expression and downregulates RANKL expression in osteoblasts, which may explain the beneficial role of icariin in preventing and treating osteoporosis.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2006年第3期222-225,共4页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金(编号30070357)
关键词 淫羊藿甙 地塞米松 成骨细胞 护骨素 核因子-ΚB受体活化因子配体 Icariin Dexamethasone Osteoblasts Osteoprotegerin Receptor activator of nuclear factor-κB ligand
  • 相关文献

参考文献9

  • 1张秀珍,韩峻峰,钱国峰,贺铭,李颖,谷磊.仙灵骨葆对PMO骨密度及IL-6、TNF-α、IGF-I的影响[J].中国骨质疏松杂志,2004,10(1):90-93. 被引量:67
  • 2Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997,89:309-319. 被引量:1
  • 3Tsuda E, Goto M, Mochizuki S, et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun, 1997,234:137-142. 被引量:1
  • 4Yasuda H, Shima N, Nakagawa N, et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG) : a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology,1998,39 : 1329-1337. 被引量:1
  • 5Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteogrotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA, 1998,95 :3597-3602. 被引量:1
  • 6Weinstein RS, Jilka RL, Parfitt AM, et al. Inhibition of esteoblastogenesis and promotion of apoptesis of osteoblasts and osteocytes by glycocorticoids. J Clin Invest, 1998,102:274-282. 被引量:1
  • 7Pydziel S, Canalis E. Cortisol repression of insulin-like growth factor Ⅱ receptor transcription in skeletal cell cultures. Endocrinology, 1995,136 : 4254 -5460. 被引量:1
  • 8Huang JC, Sakata T, Pfleger LL, et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res, 2004,19:235-244. 被引量:1
  • 9Hofbaner LC, Viereck V, Grundker C, et al. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular esteoblasts. J Cell Biochem, 2002,84:725-735. 被引量:1

二级参考文献10

共引文献66

同被引文献908

引证文献65

二级引证文献619

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部